298 related articles for article (PubMed ID: 30471715)
1. rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial.
Ley D; Hallberg B; Hansen-Pupp I; Dani C; Ramenghi LA; Marlow N; Beardsall K; Bhatti F; Dunger D; Higginson JD; Mahaveer A; Mezu-Ndubuisi OJ; Reynolds P; Giannantonio C; van Weissenbruch M; Barton N; Tocoian A; Hamdani M; Jochim E; Mangili A; Chung JK; Turner MA; Smith LEH; Hellström A;
J Pediatr; 2019 Mar; 206():56-65.e8. PubMed ID: 30471715
[TBL] [Abstract][Full Text] [Related]
2. Continuous longitudinal infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants: Evaluation of feasibility in a phase II study.
Hansen-Pupp I; Hellström A; Hamdani M; Tocoian A; Kreher NC; Ley D; Hallberg B
Growth Horm IGF Res; 2017 Oct; 36():44-51. PubMed ID: 28934640
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of IL-6 and IGFBP-1 predict low serum IGF-1 levels during continuous infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants.
Klevebro S; Hellgren G; Hansen-Pupp I; Wackernagel D; Hallberg B; Borg J; Pivodic A; Smith L; Ley D; Hellström A
Growth Horm IGF Res; 2020 Feb; 50():1-8. PubMed ID: 31756675
[TBL] [Abstract][Full Text] [Related]
4. IGF-I in the clinics: Use in retinopathy of prematurity.
Hellström A; Ley D; Hansen-Pupp I; Hallberg B; Ramenghi LA; Löfqvist C; Smith LE; Hård AL
Growth Horm IGF Res; 2016; 30-31():75-80. PubMed ID: 27720550
[TBL] [Abstract][Full Text] [Related]
5. Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants.
Chung JK; Hallberg B; Hansen-Pupp I; Graham MA; Fetterly G; Sharma J; Tocoian A; Kreher NC; Barton N; Hellström A; Ley D
Pediatr Res; 2017 Mar; 81(3):504-510. PubMed ID: 27870826
[TBL] [Abstract][Full Text] [Related]
6. Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants:
Horsch S; Parodi A; Hallberg B; Malova M; Björkman-Burtscher IM; Hansen-Pupp I; Marlow N; Beardsall K; Dunger D; van Weissenbruch M; Smith LEH; Hamdani M; Mangili A; Barton N; Ramenghi LA; Hellström A; Ley D;
Front Pediatr; 2020; 8():517207. PubMed ID: 33163463
[No Abstract] [Full Text] [Related]
7. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
Cayabyab R; Ramanathan R
Neonatology; 2016; 109(4):369-76. PubMed ID: 27251645
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety.
Ley D; Hansen-Pupp I; Niklasson A; Domellöf M; Friberg LE; Borg J; Löfqvist C; Hellgren G; Smith LE; Hård AL; Hellström A
Pediatr Res; 2013 Jan; 73(1):68-74. PubMed ID: 23095978
[TBL] [Abstract][Full Text] [Related]
9. Pilot dose-ranging of rhIGF-1/rhIGFBP-3 in a preterm lamb model of evolving bronchopulmonary dysplasia.
Albertine KH; Dahl MJ; Rebentisch A; Dawson E; Nabi A; Bowen S; Miers C; Wang Z; Yang H; Yu B; Null DM; Keefe D; Chung JK; Zhou Z; Barton N; Carey G; Ward R
Pediatr Res; 2023 May; 93(6):1528-1538. PubMed ID: 36030318
[TBL] [Abstract][Full Text] [Related]
10. Insulin-Like Growth Factor 1 in the Preterm Rabbit Pup: Characterization of Cerebrovascular Maturation following Administration of Recombinant Human Insulin-Like Growth Factor 1/Insulin-Like Growth Factor 1-Binding Protein 3.
Gram M; Ekström C; Holmqvist B; Carey G; Wang X; Vallius S; Hellström W; Ortenlöf N; Agyemang AA; Smith LEH; Hellström A; Mangili A; Barton N; Ley D
Dev Neurosci; 2021; 43(5):281-295. PubMed ID: 34218224
[TBL] [Abstract][Full Text] [Related]
11. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth.
Hellström A; Engström E; Hård AL; Albertsson-Wikland K; Carlsson B; Niklasson A; Löfqvist C; Svensson E; Holm S; Ewald U; Holmström G; Smith LE
Pediatrics; 2003 Nov; 112(5):1016-20. PubMed ID: 14595040
[TBL] [Abstract][Full Text] [Related]
12. Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial.
Phelps DL; Watterberg KL; Nolen TL; Cole CA; Cotten CM; Oh W; Poindexter BB; Zaterka-Baxter KM; Das A; Lacy CB; Scorsone AM; Walsh MC; Bell EF; Kennedy KA; Schibler K; Sokol GM; Laughon MM; Lakshminrusimha S; Truog WE; Garg M; Carlo WA; Laptook AR; Van Meurs KP; Carlton DP; Graf A; DeMauro SB; Brion LP; Shankaran S; Orge FH; Olson RJ; Mintz-Hittner H; Yang MB; Haider KM; Wallace DK; Chung M; Hug D; Tsui I; Cogen MS; Donahue JP; Gaynon M; Hutchinson AK; Bremer DL; Quinn G; He YG; Lucas WR; Winter TW; Kicklighter SD; Kumar K; Chess PR; Colaizy TT; Hibbs AM; Ambalavanan N; Harmon HM; McGowan EC; Higgins RD;
JAMA; 2018 Oct; 320(16):1649-1658. PubMed ID: 30357297
[TBL] [Abstract][Full Text] [Related]
13. Inositol in preterm infants at risk for or having respiratory distress syndrome.
Howlett A; Ohlsson A; Plakkal N
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD000366. PubMed ID: 31283839
[TBL] [Abstract][Full Text] [Related]
14. Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial.
Hellström A; Nilsson AK; Wackernagel D; Pivodic A; Vanpee M; Sjöbom U; Hellgren G; Hallberg B; Domellöf M; Klevebro S; Hellström W; Andersson M; Lund AM; Löfqvist C; Elfvin A; Sävman K; Hansen-Pupp I; Hård AL; Smith LEH; Ley D
JAMA Pediatr; 2021 Apr; 175(4):359-367. PubMed ID: 33523106
[TBL] [Abstract][Full Text] [Related]
15. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
[TBL] [Abstract][Full Text] [Related]
16. Safety aspects of longitudinal administration of IGF-I/IGFBP-3 complex in neonatal mice.
Hellgren G; Han W; Wang X; Löfqvist C; Hagberg H; Mallard C; Hellström A
Growth Horm IGF Res; 2011 Aug; 21(4):205-11. PubMed ID: 21696987
[TBL] [Abstract][Full Text] [Related]
17. Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications.
Salamat-Miller N; Turner MA; Bandekar A; Dixit N; Jochim E; Mangum B; McPherson C; Tenjarla S; Singh S; Hwang YS; Barton N
World J Pediatr; 2023 Jan; 19(1):58-67. PubMed ID: 36344872
[TBL] [Abstract][Full Text] [Related]
18. A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants.
Löfqvist C; Niklasson A; Engström E; Friberg LE; Camacho-Hübner C; Ley D; Borg J; Smith LE; Hellström A
Pediatr Res; 2009 May; 65(5):574-9. PubMed ID: 19190540
[TBL] [Abstract][Full Text] [Related]
19. Development of Protein-Specific Analytical Methodologies to Evaluate Compatibility of Recombinant Human (rh)IGF-1/rhIGFBP-3 with Intravenous Medications Co-Administered to Neonates.
Salamat-Miller N; Qu W; Chadwick JS; McPherson C; Salinas PA; Turner M; Wang D; Barton N
J Pharm Sci; 2022 May; 111(5):1486-1496. PubMed ID: 34717953
[TBL] [Abstract][Full Text] [Related]
20. The clinical burden of extremely preterm birth in a large medical records database in the United States: complications, medication use, and healthcare resource utilization.
Siffel C; Hirst AK; Sarda SP; Chen H; Ferber J; Kuzniewicz MW; Li DK
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10271-10278. PubMed ID: 36170979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
